|
|
Volumn 22, Issue 3, 2007, Pages 258-262
|
|
Safety and tolerability of once-daily versus twice-daily memantine: A randomised, double-blind study in moderate to severe Alzheimer's disease
a
|
|
Author keywords
Alzheimer's disease; Memantine; NMDA; Once daily dose; Simplified titration
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
MEMANTINE;
ADULT;
AGED;
ALZHEIMER DISEASE;
APATHY;
ARTICLE;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELUSION;
DEPRESSION;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DISEASE SEVERITY;
DOSAGE SCHEDULE COMPARISON;
DOUBLE BLIND PROCEDURE;
DRUG DOSE TITRATION;
DRUG FATALITY;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HALLUCINATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MINI MENTAL STATE EXAMINATION;
PNEUMONIA;
RANDOMIZED CONTROLLED TRIAL;
RECOMMENDED DRUG DOSE;
RHINITIS;
SIDE EFFECT;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VITAL SIGN;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
ANXIETY;
DOPAMINE AGENTS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEAST-SQUARES ANALYSIS;
MALE;
MEMANTINE;
MENTAL DISORDERS;
NEUROPSYCHOLOGICAL TESTS;
PATIENT SELECTION;
SAFETY;
TREATMENT OUTCOME;
|
|
EID: 33947283745
PISSN: 08856230
EISSN: 10991166
Source Type: Journal
DOI: 10.1002/gps.1752 Document Type: Article |
|
Times cited : (37)
|
|
References (9)
|
